Report copyright - Second-line afatinib for advanced squamous cell carcinoma …...FGF12 33.3 33.3 44.4 26.5 55.6 60.6 0 10 20 30 40 50 60 70 80 90 100 *ErbB+ †FGF+ ErbB and FGF family aberrations
Please pass captcha verification before submit form
Please pass captcha verification before submit form